Dn B Asset Management As Cara Therapeutics, Inc. Transaction History

Dn B Asset Management As

  • $19.9 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 06, 2021
SELL
$12.38 - $29.19 $213,059 - $502,359
-17,210 Closed
0 $0
Q1 2021

Apr 15, 2021
SELL
$15.07 - $21.71 $30,140 - $43,420
-2,000 Reduced 10.41%
17,210 $373,000
Q4 2020

Jan 19, 2021
BUY
$12.72 - $16.16 $244,351 - $310,433
19,210 New
19,210 $290,000

Others Institutions Holding CARA

# of Institutions
88
Shares Held
16.5M
Call Options Held
55K
Put Options Held
500
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email